immunomodulator comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-11-11. Numbers and descriptions here follow the published literature rather than marketing material.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
| Property | Value | Notes |
|---|---|---|
| Class | Synthetic peptide | 28 residues; not a small-molecule compound |
| Molecular mass | About 3,106 Da | Monoisotopic mass of the unmodified chain |
| N-terminal group | Acetylated serine | Present in both native and synthetic forms |
| Secondary structure | Disulfide-constrained loop | One bridge between two cysteine residues |
| Typical source | Solid-phase synthesis | Early isolates came from bovine thymus extracts |
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Where sickle cell disease is suspected, several tests can be used. Often, a simpler, cheaper test is applied first, with a more complex test, such as DNA analysis, used to confirm a positive result. Two tests that are specific to sickle cell disease:
It also condemned Israel's attacks on Syrian territory and its "continued violations of international laws and norms". Hamas: Hamas issued a statement expressing full solidarity with Syria and described the Israeli attacks as a "blatant violation of international laws" and called for a strong response to confront them. Hezbollah: Hezbollah condemned the Israeli strikes, describing them as against international law.
==== Pressure ulcers ==== Another leading type of chronic wounds is pressure ulcers, which usually occur in people with conditions such as paralysis that inhibit movement of body parts that are commonly subjected to pressure such as the heels, shoulder blades, and sacrum. Pressure ulcers are caused by ischemia that occurs when pressure on the tissue is greater than the pressure in capillaries, and thus restricts blood flow into the area. Muscle tissue, which needs more oxygen and nutrients than skin does, shows the worst effects from prolonged pressure. As in other chronic ulcers, reperfusion injury damages tissue.
Marihuana prensada ('pressed marijuana') is a cannabis-derived product widespread among the lower classes of South America, especially in the 1990s. Locally it is known as "paraguayo" or "paragua", since its main producer is Paraguay. Marijuana is dried and mixed with binding agents that make it toxic and highly harmful to health. It is cut into the shape of bricks (ladrillos) and sold cheaply in Argentina, Brazil, Chile, Peru, Venezuela, and the United States.
Sources: en.wikipedia.org
== Prevention == A primary means of limiting risk from aflatoxins in the food supply is food hygiene in the commercial commodity supply chain, such as rejecting moldy grain for use in food processing plants and testing of batches of ingredients for aflatoxin levels before adding them to the mix. Regulatory agencies such as the FDA set limits on acceptable levels. Grain drying itself, which is necessary for viable combine harvesting in many regions, assists in this effort by preventing stored grain from being too damp in the first place. The use of nixtamalization, the processing of maize or other grains by soaking and cooking in alkali solution, greatly reduces aflatoxin concentrations. There is very limited evidence to show that agricultural and nutritional education can reduce exposure to aflatoxin in low to middle-income countries.
== Indications == The decision to initiate dialysis or hemofiltration in patients with kidney failure depends on several factors. These can be divided into acute or chronic indications. Depression and kidney failure symptoms can be similar to each other. It is important that there is open communication between a dialysis team and the patient. Open communication will allow giving a better quality of life. Knowing the patients' needs will allow the dialysis team to provide more options like: changes in dialysis type like home dialysis for patients to be able to be more active or changes in eating habits to avoid unnecessary waste products.
Federalism was first proposed by ministers from both the colony and protectorates; the suggested amalgamation would be beneficial, they argued, in terms of economics, race, religion and languages. However, the step was illogical in terms of Arab Nationalism, for it was taken just prior to some impending elections, and was against the wishes of Aden Arabs, notably many of the trade unions. An additional problem was the huge disparity in political development, as at the time Aden colony was some way down the road to self-government and in the opinion of some dissidents, political fusion with the autocratic and backward Sultanates was a step in the wrong direction. In the federation, Aden colony was to have 24 seats on the new council, while each of the eleven sultanates was to have six. While the federation as a whole would have financial and military aid from Britain. The federation was opposed by the majority of the people of Aden, leading to a series of strikes and protest marches while the elections for the council were rigged in favour of supporters of the federation. Right from the start, the federation was seen as illegitimate. On 18 January 1963, the colony was reconstituted as the State of Aden, within the new Federation of South Arabia. With this Sir Charles Johnston stepped down as the last Governor of Aden. Many of the problems that Aden had suffered in its time as a colony did not improve on federation. Internal disturbances continued and intensified, leading to the Aden Emergency and the final departure of British troops.
== Health effects == There is inconclusive clinical data whether specific vitamin K2 supplementation confers any beneficial effects compared to vitamin K1 which is the most common form in supplements. In vitro studies show certain cellular effects of vitamin K2 in bone which are not observed with the K1 variant (including bone marrow stem cell (BMSC) proliferation, and stimulation of osteoblast differentiation). The effects of vitamin K2 appear to be accentuated when combined with vitamin D and in the setting of osteoporosis.
In the two weeks prior to the disappearance he created a total obsession with him, he didn't leave him alone". After speaking against Dias, Silva said that he and the other witnesses were scared and did not receive police protection. In 2011, João André Mendonça that when he was giving his testimony in GNR (Republican National Guard) in 1998, Dias asked him to "not open his mouth" and that "the authorities should close the borders (...) Maybe they still have time". In 2012, Paulo Gomes, Dias' lawyer, declared that "Mister Afonso isn't talking because his freedom is on the line". In the same year Dias said that he was going to talk about what happened with Rui Pedro, but he would do it outside of the courtroom. In an interview to Grande Revista of RTP in 2012, he said that he does not talk more because of all the help he gave to authorities that only served for his prosecution thirteen years later. When questioned about Rui Pedro he answered after a long silence: "As I see it... I don't know... three weeks after another kid went missing in Famalicão. Either it was a kidnapping or he fell in a well... I don't know". Later (in 2018), he said he did not have a theory on what happened with the boy. Ricardo Sá Fernandes, Mendonça family's lawyer, stated in 2017: "I keep saying that what I would really like is for Afonso Dias to tell us what happened with Rui Pedro after they left the prostitute. But he didn't say anything in court, and continues to not reveal what I would like for him to reveal. And, I repeat, what I would really like would be for him to say what he knows."
Sources: en.wikipedia.org
Caregiving is the ongoing physical, social, emotional support provided to people living with dementia, helping them carry out everyday activities. Since AD has no cure and it gradually renders people incapable of tending to their own needs, caregiving is essentially the treatment and must be carefully managed over the course of the disease. During the early and moderate stages, modifications to the living environment and lifestyle can increase safety and reduce caretaker burden. Examples of such modifications are the adherence to simplified routines, the placing of safety locks, the labeling of household items to cue the person with the disease or the use of modified daily life objects. Per the American Academy of Family Physicians, the use of physical restraints is discouraged. Use of the "VIPS" framework "(Valuing people, Individualised care, Personal perspectives, Social environment)" has been shown to reduce hours per day of restraint. If eating becomes problematic, food will need to be prepared in smaller pieces or even puréed. When swallowing difficulties arise, the use of feeding tubes may be required. In such cases, the medical efficacy and ethics of continuing feeding is an important consideration of the caregivers and family members. During the final stages of the disease, treatment is centred on relieving discomfort until death, often with the help of hospice. The wellbeing of caregivers themselves is an important aspect of AD caregiving.
== Diagnosis == Laboratory investigations usually show elevated creatine kinase, myopathic/dystrophic muscle pathology and altered α-dystroglycan. Antenatal diagnosis is possible in families with known mutations. Prenatal ultrasound may be helpful for diagnosis in families where the molecular defect is unknown.
== Awards == In 1986, Novotny was given the Award in Chromatography from the American Chemical Society. Novotny received the ANACHEM award in 1992. This award is given to outstanding analytical chemists for teaching, research, administration or other activities which have advanced of the field. Novotny was also selected as the LCGC Lifetime Achievement award recipient in 2019.
The aroma chemicals acetamide and cumarine have been found in the e-cigarette vapor. Acrylonitrile and ethylbenzene have been found in the e-cigarette vapor. Benzene and 1,3-Butadiene have been found in the e-cigarette vapor at many-fold lower than in cigarette smoke. Some e-cigarettes contain diacetyl and acetaldehyde in the e-cigarette vapor. Diacetyl and acetylpropionyl have been found at greater levels in the e-cigarette vapor than is accepted by the National Institute for Occupational Safety and Health, although diacetyl and acetylpropionyl are normally found at lower levels in e-cigarettes than with traditional cigarettes. A 2018 PHE report stated that diacetyl was identified at hundreds of times in lesser amounts than found in cigarette smoke. A 2016 WHO report found that acetaldehyde from second-hand vapor was between two and eight times greater compared to background air levels.
Sources: en.wikipedia.org
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.
The single bridge between two cysteine residues holds the chain in a folded loop that influences its shape and its behavior in solution. Loss of the bridge through reduction or oxidation shifts chromatographic retention and is tracked during stability work.
It is a defined 28-residue sequence derived from a larger precursor, whereas many other thymic preparations are mixtures of several polypeptides. Its acetylated amino terminus and single disulfide bridge distinguish it chemically from unrelated thymic extracts.
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.